Recursion Pharmaceuticals, Inc. (RXRX)
Sector: Healthcare
Industry: Biological Products, (No Diagnostic Substances)
Country: United States
Exchange: NASDAQ
Market cap: $2.05B
Recursion Pharmaceuticals Inc is a clinical-stage biotechnology company. The company is decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the lives of patients and industrializing drug discovery.
Latest financial period: June 30, 2026
Filed with the SEC: August 5, 2026
Estimated earnings date: November 4, 2026
Profit #1480 of 1484 companies
| | Jun 26 | Mar 26 | Dec 25 | Sep 25 |
|---|
| ROIC | -132.9% | -126.5% | -124.7% | -200.0% |
Growth #1322 of 1484 companies
Payout #1117 of 1484 companies
Safety #869 of 1484 companies
Price #1474 of 1484 companies
